Market Tracker

07/22 5:16pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

21.03
Delayed Data
As of Jul 22
 +0.03 / +0.14%
Today’s Change
9.51
Today|||52-Week Range
23.30
+56.47%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close21.00
Today’s open20.96
Day’s range20.84 - 21.21
Volume211,178
Average volume (3 months)577,045
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+125.51%
Earnings growth (next 5 years)+53.00%
Revenue growth (last year)+18.34%
P/E ratio61.3
Price/Sales4.76
Price/Book8.67

Competitors

 Today’s
change
Today’s
% change
MGNXMacroGenics Inc+0.23+0.80%
CXRXConcordia Internatio...-1.00-4.89%
TBPHTheravance Biopharma...+0.66+2.96%
DERMDermira Inc-0.29-0.91%
Data as of 3:59pm ET, 07/22/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$0.13
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts